June 22, 2007 - CardioDynamics, an impedance cardiography (ICG) technology developer, announced that it has reached an agreement to sell its Vermed unit to the subsidiary's management team for a cash purchase price of $8 million, allowing CardioDynamics to focus its resources on its proprietary ICG business, which continues to hold the highest growth potential.
